Brief: Theradiag enters into master services agreement with UCB

Theradiag SA

03/02/2015 17:02

Feb 3 (Reuters) - Theradiag SA  ALTHE.PA : 
    * Entered into a master services agreement with UCB, with a 
first application for anti-TNF biologic certolizumab pegol 
(brand name Cimzia) 
    * Theradiag will perform services for UCB on a project basis 
 
Source text for Eikon:  ID:nBw6wCk2Ta  
Further company coverage:  ALTHE.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;)) 
 
Keywords: THERADIAG/BRIEF